why choose us

300×250 Ad Slot

Drug FDA Status

Showing 120 of 144 result(s) (Page 12 of 15)
Drug Name: Sohonos

Active Ingredient: palovarotene

Approval Date: 2023-08-16

Description: To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva

Drug Name: Elrexfio

Active Ingredient: elranatamab-bcmm

Approval Date: 2023-08-14

Description: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy

Drug Name: Talvey

Active Ingredient: talquetamab-tgvs

Approval Date: 2023-08-09

Description: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies

Drug Name: Izervay

Active Ingredient: avacincaptad pegol

Approval Date: 2023-08-04

Description: To treat geographic atrophy secondary to age-related macular degeneration

Drug Name: Zurzuvae

Active Ingredient: zuranolone

Approval Date: 2023-08-04

Description: To treat postpartum depression 
Press Release

Drug Name: Xdemvy

Active Ingredient: lotilaner

Approval Date: 2023-07-25

Description: To treat Demodex blepharitis

Drug Name: Vanflyta

Active Ingredient: quizartinib

Approval Date: 2023-07-20

Description: To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria

Drug Name: Beyfortus

Active Ingredient: nirsevimab-alip

Approval Date: 2023-07-17

Description: To prevent respiratory syncytial virus (RSV) lower respiratory tract disease
Press Release
Drug Trials Snapshot

Drug Name: Ngenla

Active Ingredient: somatrogon-ghla

Approval Date: 2023-06-27

Description: To treat growth failure due to inadequate secretion of endogenous growth hormone
Drug Trials Snapshot

Drug Name: Rystiggo

Active Ingredient: rozanolixizumab-noli

Approval Date: 2023-06-26

Description: To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive

300×250 Ad Slot